456 related articles for article (PubMed ID: 14504112)
1. An update on aspirin in the primary prevention of cardiovascular disease.
Eidelman RS; Hebert PR; Weisman SM; Hennekens CH
Arch Intern Med; 2003 Sep; 163(17):2006-10. PubMed ID: 14504112
[TBL] [Abstract][Full Text] [Related]
2. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin.
Bartolucci AA; Howard G
Am J Cardiol; 2006 Sep; 98(6):746-50. PubMed ID: 16950176
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
[TBL] [Abstract][Full Text] [Related]
5. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
6. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
Hennekens CH; Sacks FM; Tonkin A; Jukema JW; Byington RP; Pitt B; Berry DA; Berry SM; Ford NF; Walker AJ; Natarajan K; Sheng-Lin C; Fiedorek FT; Belder R
Arch Intern Med; 2004 Jan; 164(1):40-4. PubMed ID: 14718320
[TBL] [Abstract][Full Text] [Related]
7. Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.
Zhang C; Sun A; Zhang P; Wu C; Zhang S; Fu M; Wang K; Zou Y; Ge J
Diabetes Res Clin Pract; 2010 Feb; 87(2):211-8. PubMed ID: 19853947
[TBL] [Abstract][Full Text] [Related]
8. Aspirin to prevent heart attack and stroke: what's the right dose?
Dalen JE
Am J Med; 2006 Mar; 119(3):198-202. PubMed ID: 16490462
[TBL] [Abstract][Full Text] [Related]
9. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Bhatt DL; Topol EJ;
Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995
[TBL] [Abstract][Full Text] [Related]
11. [Acetylsalicylic acid in primary prevention of cardiovascular events; literature study].
Bredie SJ; Wollersheim HC; Verheugt FW; Thien T
Ned Tijdschr Geneeskd; 2002 Jan; 146(2):68-72. PubMed ID: 11820060
[TBL] [Abstract][Full Text] [Related]
12. [Primary prevention of cardiovascular diseases with acetylsalicylic acid].
Waltering A; Hemkens L; Florack C
Dtsch Med Wochenschr; 2005 Dec; 130(49):2847-52. PubMed ID: 16317615
[TBL] [Abstract][Full Text] [Related]
13. Low-dose aspirin for primary prevention of cardiovascular disease.
Bredie SJ; Wollersheim H; Verheugt FW; Thien T
Semin Vasc Med; 2003 May; 3(2):177-84. PubMed ID: 15199480
[TBL] [Abstract][Full Text] [Related]
14. Aspirin and primary cardiovascular prevention. Uncertain balance between benefits and risks.
Prescrire Int; 2010 Nov; 19(110):258-61. PubMed ID: 21284360
[TBL] [Abstract][Full Text] [Related]
15. Aspirin use in the prevention of cardiovascular events.
Crutcher JM; Mallonee S; Daniels C
J Okla State Med Assoc; 2007 Oct; 100(10):383-7. PubMed ID: 18085095
[TBL] [Abstract][Full Text] [Related]
16. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Ridker PM; Cushman M; Stampfer MJ; Tracy RP; Hennekens CH
N Engl J Med; 1997 Apr; 336(14):973-9. PubMed ID: 9077376
[TBL] [Abstract][Full Text] [Related]
17. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
18. Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.
Berger JS; Brown DL; Becker RC
Am J Med; 2008 Jan; 121(1):43-9. PubMed ID: 18187072
[TBL] [Abstract][Full Text] [Related]
19. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
Arjomand H; Cohen M; Ezekowitz MD
J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
[TBL] [Abstract][Full Text] [Related]
20. Use of acetylsalicylic acid by physicians and in the community.
Mahon J; Steel K; Feagan BG; Laupacis A; Pederson LL
CMAJ; 1991 Nov; 145(9):1107-16. PubMed ID: 1751930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]